No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs7456817 |
chr7:2913371-2913372 |
Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs560259115 |
chr7:2913375-2913376 |
Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs182439713 |
chr7:2913389-2913390 |
Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs146371918 |
chr7:2913415-2913416 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs562437582 |
chr7:2913427-2913428 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs73035208 |
chr7:2913477-2913478 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs7778433 |
chr7:2913479-2913480 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs545418603 |
chr7:2913496-2913497 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs73035210 |
chr7:2913531-2913532 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs564242013 |
chr7:2913589-2913590 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs533227380 |
chr7:2913590-2913591 |
Enhancers Weak transcription Bivalent Enhancer
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs117175142 |
chr7:2913608-2913609 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs376074657 |
chr7:2913609-2913610 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs187955333 |
chr7:2913621-2913622 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs549697449 |
chr7:2913622-2913623 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs193009366 |
chr7:2913641-2913642 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs112443025 |
chr7:2913650-2913651 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs537851459 |
chr7:2913659-2913660 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs147971669 |
chr7:2913664-2913665 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs371041823 |
chr7:2913665-2913666 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs371949757 |
chr7:2913667-2913668 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs557757022 |
chr7:2913676-2913677 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs571379363 |
chr7:2913698-2913699 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs556215463 |
chr7:2913701-2913702 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs553563899 |
chr7:2913714-2913715 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs573823414 |
chr7:2913720-2913721 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs542445864 |
chr7:2913733-2913734 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs386709389 |
chr7:2913736-2913737 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs575883377 |
chr7:2913737-2913738 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs62441404 |
chr7:2913738-2913739 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs62441405 |
chr7:2913739-2913740 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
32 |
rs540751577 |
chr7:2913740-2913741 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs532322679 |
chr7:2913741-2913742 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs560380758 |
chr7:2913742-2913743 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs2398570 |
chr7:2913743-2913744 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs137927125 |
chr7:2913745-2913746 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs569575456 |
chr7:2913746-2913747 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs532006796 |
chr7:2913748-2913749 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs142496323 |
chr7:2913750-2913751 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs571290860 |
chr7:2913752-2913753 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs185735801 |
chr7:2913755-2913756 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs553870175 |
chr7:2913757-2913758 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs567207244 |
chr7:2913758-2913759 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs73035212 |
chr7:2913761-2913762 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs189496154 |
chr7:2913771-2913772 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs575949381 |
chr7:2913773-2913774 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs150509142 |
chr7:2913774-2913775 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs139439280 |
chr7:2913775-2913776 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs149669642 |
chr7:2913776-2913777 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs144583977 |
chr7:2913778-2913779 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
9 gene(s)
|
Overlapped CNVs
|
n/a
|